Chapter16A woman sitting at the edge of a backyard pool at golden hour, fastening her sandals with a small smile
Google Ads

Google Ads for Podiatrists · Chapter 16 of 16 · All chapters

Toenail Lasers Are FDA-Cleared for Clearer Nails, Not a Cure. Sell the Package on What It Actually Does.

Laser for fungal nails is FDA-cleared for a temporary increase of clear nail, not a cure. How podiatry ads sell laser, shockwave and PRP honestly.

David SmaniaFounder, BrandRocket12 min read · September 28, 2026

A patient who hasn't worn sandals in five years finds a podiatry page that says a laser "kills the fungus" in a 30-minute visit. They pay for a package, the nail looks the same a month later, and they post about it on Reddit. The laser may have done exactly what it's cleared to do. The page promised something else.

Laser treatment for fungal nails, shockwave for heel pain and PRP injections are some of the most profitable things a podiatry practice sells. They're also the services where ad copy and websites drift furthest from what the treatment is actually cleared, approved or allowed to do. This last chapter covers what each one can honestly claim, and how to sell it anyway.

The FDA cleared the laser to make more of the nail clear, for a while. "Cure" is the practice's word, not the FDA's.
Chapter 16 of 16

The FDA Cleared the Laser for "Temporary Increase of Clear Nail"

The FDA files toenail fungus lasers under a product code whose name spells out what they're for: "lasers for temporary increase of clear nail in patients with onychomycosis," the medical name for nail fungus. The first was cleared in 2010. The FDA's database lists 19 clearances under that code, the latest in March 2026.

Read the wording closely. The cleared use isn't killing fungus, and it isn't a cure. It's more of the nail growing in clear, for a time.

The second word to read closely is "cleared." A clearance (the FDA's 510(k) process) means the device is substantially equivalent to one already on the market. It isn't an approval, and federal rules say so directly: a clearance "does not in any way denote official approval of the device," and anything that creates that impression "is misleading." The FTC's health claims guidance gives nearly this exact case as an example of deception: a cleared device advertised as "FDA Approved," with claims beyond its cleared use.

So "FDA-approved laser cures toenail fungus" is wrong three ways. The device is cleared, not approved. The cleared use is a temporary increase in clear nail. And "cure" is the kind of improbable-result claim Google's misrepresentation policy doesn't allow. "FDA-cleared laser treatment for toenail fungus" is accurate, and it's still a strong line.

Patients Search for the Laser, Then Ask Reddit Whether It Works

The demand is real. "Laser for fungal nails" and the searches Google groups with it draw about 14,800 a month in the United States, and price searches like "fungal nail laser treatment price" another 1,000.

What patients say afterward is mixed. In the Google reviews we read for podiatry practices in our example market, Los Angeles, laser shows up as praise for slow progress: "I started laser treatment a month ago, and I can see that my nails are getting better every day." On Reddit, it shows up as a price question and a doubt. One poster wrote: "He told me he could 'cure' the toenail fungus with a one time laser treatment for $500 per nail." Another, in the same thread: "Years ago, I paid $1000 for a laser treatment.... Also didn't work." The feelings underneath are embarrassment and sandals: "I haven't worn sandals for the last 5 years."

Now look at what practices publish. Seven of the 12 podiatry sites in our example-market sample offer laser treatment for fungal nails. Their pages say the laser "kills the fungus," "vaporizes the fungus," or is "designed to eradicate fungus." One page reports "over 88% of treated patients show significant improvement" and says "in most cases the nail fungus pathogen is completely eliminated." Another calls its laser "an FDA-approved treatment designed to target and eliminate toenail fungus," with "no side effects."

One site gets it right: "Laser treatment may improve the appearance of fungal nails for some patients. Results vary, and it can take months to see changes because toenails grow slowly." That's accurate, and it still sells.

Only 1 of the 82 podiatry ads we read mentioned the laser at all. So the claims aren't in the ads yet. They're on the pages, which is exactly where AI Max reads when it writes new headlines (Chapter 13), and where the patient lands after the click.

An Honest Laser Package Names the Sessions, the Months and the Full Price

Laser is sold as a package, and the package is where the ad has to be most precise. Among practices that post their prices online, laser packages ran from $550 for all ten toes to $2,495 for both feet, depending on how many feet, nails and sessions were included.

Google's misrepresentation policy covers this directly: an ad has to make clear the full expense a patient will pay, both at signup and afterward. A "$99 laser" headline that turns into a $1,200 course on the phone is exactly that. If the ad mentions a price, it should be the price of what the patient will actually buy.

A truthful laser page answers the questions Reddit asks:

Two rules make the fine print matter more. First, "results vary" doesn't rescue a dramatic claim. The FTC says testimonials that report results more dramatic than patients can generally expect "are likely to be deceptive," and disclaimers like "Results not typical" "don't cure the deception." A before-and-after photo of a perfectly clear nail is that kind of testimonial. Google's clickbait policy separately limits before-and-after images in ads. Keep clinical photos on the page, with context, and out of the ad.

Second, a laser package sold with a guarantee has to show its refund terms where patients can find them; that's Google's condition for any guaranteed result. If the practice won't put a money-back policy on the page, the word "guarantee" stays out of the ad.

Laser is a self-pay service, so federal rules add one more duty. Under the No Surprises Act, a practice owes self-pay patients a written Good Faith Estimate when they ask about cost or schedule the service, and it has to post a notice that estimates are available. A price in the ad doesn't replace it.

Ad lines that stay on the right side:

Shockwave Is Approved for Heel Pain That Hasn't Healed in Six Months

Shockwave therapy, or ESWT, has a narrower approval than many pages suggest. In the FDA's approval database, the shockwave approvals we found for the foot, six of them between 2000 and 2016, are all for the same thing: chronic plantar fasciitis at the heel, in adults, with pain lasting six months or more that hasn't responded to conservative treatment. A separate 2017 authorization covers one device for diabetic foot ulcers. We found no approval for Achilles tendon pain.

That's a useful ad, not a limit on one. "Heel Pain for Six Months?" speaks directly to the long-suffering patient Chapter 11 described, the one who has tried insoles, stretches and a cortisone shot. It matches the approved use word for word.

The pages go further. 8 of the 12 sites we studied offer or mention shockwave. One says it's "effective for 90%+ of patients who undergo the treatment." Others promise it will "eliminate chronic heel pain at its source" or make "damaged tissue gradually regenerate." Some practices use lower-energy devices cleared for other uses, which we didn't research. Whatever device a practice uses, its ad should claim what that device's own FDA paperwork says, and no more.

Shockwave is also sold in sessions. Posted prices ran $100 to $200 per session, with four to six sessions recommended. The same full-expense rule applies: say how many sessions a typical course takes, and what the course costs.

Google Won't Run a PRP Ad. Advertise the Heel Pain Instead.

PRP (platelet-rich plasma) is a different problem, and wording won't solve it. Google names both PRP and stem cell therapy as examples in its speculative and experimental treatment policy, and the answer for a clinic is no. Its one exception in the United States is for a company holding an FDA license or approval for a cell or gene therapy, and a podiatry clinic performing the injection isn't that company.

For podiatry, the bigger exposure is the website. The FDA's consumer alert says the only approved stem cell products are blood-forming cells from umbilical cord blood, and that products made from amniotic fluid, umbilical cord blood, fat tissue or Wharton's jelly haven't been approved for any orthopedic condition such as tendonitis, or to treat chronic pain. When the FDA sent warning letters over these products in 2024, 2025 and August 2026, it cited the companies' and clinics' own websites and social media pages as evidence of what they were selling the products to do.

In our example market, 8 of the 12 podiatry sites mention PRP or stem cells, and three give them a page of their own. The wording goes well past what the FDA has approved: "Regenerative treatments - Including platelet rich plasma (PRP) and amniotic stem cell therapies," and "Stem cell therapy offers a cutting-edge solution to reduce pain and promote tissue regeneration." Patients notice the sell. One Google review in our sample complained that "the provider repeatedly recommended stem cell/PRP injections, which cost thousands of dollars and also aren't covered by insurance." Where a price was posted, PRP ran $800 and $1,195.

Google doesn't say how it treats a landing page that simply lists PRP among many services, and we found nothing that settles it. So the fix starts on the site, the same way Chapter 13's audit did:

If you'd rather have someone write laser and shockwave ads that sell on what the treatments really do, and keep PRP out of the account, that's the kind of work our Google Ads management team does for podiatry practices.

A Podiatry Account Hands Google Control One Proven Step at a Time

That's all sixteen chapters, grouped the way a podiatry practice would build them:

Measure and plan

  1. Half of Podiatry Sites Book Patients on a Callback. Send That Booking Back to Google Ads With Its Click ID.
  2. Nearly Every Ingrown Toenail Search Wants It Removed. Almost No Heel Pain Search Wants a Doctor Yet.
  3. Podiatry Patients Range From a $45 Nail Visit to a $750 Pair of Orthotics. Figure Out What Each One Can Cost You.
  4. Your Heel Pain Page Already Exists. Send the Heel Pain Ad There, Not to the Home Page.
  5. Keyword Planner Hands Podiatrists Hospital Brands and Rival Doctors' Names. Every One Is a Negative Keyword.

Launch Search

  1. "Podiatrist Near Me" Is the Search You Can Predict. Broad Match Finds the Heel and Toenail Searches You Can't.
  2. A "Podiatrist" Click Costs Many Times a "Heel Hurts" Click. Bid by Hand Until You Know What a Patient Costs.
  3. Patients Grade Podiatrists on Whether They Listened. Put That in the Headline, Not "#1 in Town."
  4. Google's Defaults Are Set for Google. Change Six of Them Before a Podiatry Campaign Spends a Dollar.

Scale

  1. In Podiatry the Brand Is the Doctor's Name. Keep Performance Max From Buying It Back.
  2. Demand Gen Reaches People Living With Heel Pain Before They Ever Search for a Podiatrist.

Late and optional

  1. Podiatrists Get Their Own Local Services Ads Category. That Doesn't Make It a Launch-Day Campaign.
  2. AI Max Writes From Your Whole Website. If a Page Says "Cure," Your Ads Can Say It Too.

The podiatry rules

  1. Medicare Covers Nail Care Only for Seniors With Certain Health Conditions. Don't Promise It to the Rest.
  2. Patients Ask Whether They Need a Podiatrist or an Orthopedist. Answer It Before the Orthopedic Group's Ad Does.
  3. This chapter: selling laser and shockwave on what they're cleared and approved to do, and keeping PRP out of the ads.

The order is the point. Isolation, the exact match campaign, and the brand campaign come first, because they give the practice control and clean data. Exploration, the broad match campaign, follows once the account reaches about 30 quality conversions a month. (Both names are ours, not Google's.) Each step after that hands Google more of the decisions, and each waits until the one before it has proven what a booked patient costs: Performance Max, then Demand Gen once the daily budget can reach ten times the target cost per lead, Local Services Ads as an optional test, and AI Max last.

The podiatry guide's home page keeps all sixteen chapters in one place.

David Smania · Founder, BrandRocket

25+ years running paid media for small businesses, and a low tolerance for agency theater.

Follow on LinkedIn